Literature DB >> 12030909

Acromegaly: evidence for a direct relation between disease activity and cardiac dysfunction in patients without ventricular hypertrophy.

Burkhard L Herrmann1, C Bruch, B Saller, T Bartel, S Ferdin, R Erbel, K Mann.   

Abstract

BACKGROUND AND AIMS: Cardiac abnormalities, such as cardiomegaly and congestive heart failure, occur frequently in advanced acromegaly. Abnormalities of systolic and diastolic function, mostly associated with left ventricular (LV) hypertrophy, have been reported. The impact of disease activity on LV performance in patients with normal or slightly elevated LV muscle mass has not been demonstrated. PATIENTS AND METHODS: Conventional two-dimensional/Doppler echocardiography and tissue Doppler imaging (TDI) of the mitral annulus were performed in 13 patients with active acromegaly (AA) and normal or slightly elevated LV muscle mass (< 140 g/m2) and in 19 cured/well-controlled patients (CA). A group of 21 volunteers without symptoms or signs of cardiac disease served as controls (CON). The combined myocardial performance index (Tei-Index) was determined in all patients and controls.
RESULTS: Muscle mass index of the left ventricle, ejection fraction, fractional shorting, E/ET-ratio, systolic (ST) and late diastolic (AT) annular velocities did not differ significantly between the three groups. In the AA group, the early diastolic annular velocity ET[7.13 +/- 2.11 (AA); 9.83 +/- 3.29 (CA); 10.10 +/- 1.70 m/s (CON); P < 0.05 AA vs. CA, P < 0.005 AA vs. CON] and the ET/AT-ratio [0.71 +/- 0.26 (AA); 0.95 +/- 0.33 (CA); 1.00 +/- 0.15 m/s (CON); P < 0.05 AA vs. CA, P < 0.005 AA vs. CON] were significantly reduced. Patients with AA had a longer deceleration time [209 +/- 19 (AA); 179 +/- 22 (CA); 185 +/- 26 ms (CON); P < 0.05]. The Tei-Index was significantly higher in AA in comparison with CON [0.50 +/- 0.15 (AA); 0.48 +/- 0.12 (CA); 0.41 +/- 0.10 (CON); P < 0.05 AA vs. CON]. Subjects with CA did not differ significantly from controls with respect to 2-D/Doppler echo- and TDI-derived parameters.
CONCLUSION: The data demonstrate that diastolic dysfunction can be verified by tissue Doppler imaging in patients with active acromegaly with normal or slightly elevated muscle mass of the left ventricle and seems to be related to disease activity. The Tei-Index as a sensitive combined myocardial performance index can be used to complete the assessment of systolic and diastolic LV performance in acromegalic patients.

Entities:  

Mesh:

Year:  2002        PMID: 12030909     DOI: 10.1046/j.1365-2265.2002.01528.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

1.  Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.

Authors:  Claire Briet; Mirela Diana Ilie; Emmanuelle Kuhn; Luigi Maione; Sylvie Brailly-Tabard; Sylvie Salenave; Bertrand Cariou; Philippe Chanson
Journal:  Endocrine       Date:  2018-11-05       Impact factor: 3.633

Review 2.  Acromegalic cardiomyopathy: Epidemiology, diagnosis, and management.

Authors:  Ajay N Sharma; Marilyn Tan; Ezra A Amsterdam; Gagan D Singh
Journal:  Clin Cardiol       Date:  2018-03-25       Impact factor: 2.882

3.  N-terminal pro-brain natriuretic peptide in newly diagnosed acromegaly.

Authors:  S Arikan; M Bahceci; A Tuzcu; D Gokalp
Journal:  J Endocrinol Invest       Date:  2010-09       Impact factor: 4.256

Review 4.  [Endocrine disorders and the heart].

Authors:  Onno E Janssen; K Mann; R Erbel
Journal:  Internist (Berl)       Date:  2007-03       Impact factor: 0.743

5.  Myocardial systolic strain abnormalities in patients with acromegaly: a prospective color Doppler imaging study.

Authors:  V Di Bello; F Bogazzi; A Di Cori; C Palagi; M G Delle Donne; S Gavioli; E Talini; C Cosci; C Sardella; G Tonti; E Martino; A Balbarini; M Mariani
Journal:  J Endocrinol Invest       Date:  2006-06       Impact factor: 4.256

6.  Measuring tongue volumes and visualizing the chewing and swallowing process using real-time TrueFISP imaging--initial clinical experience in healthy volunteers and patients with acromegaly.

Authors:  W Ajaj; M Goyen; B Herrmann; S Massing; S Goehde; T Lauenstein; S G Ruehm
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

7.  Anesthesia and Intensive care implications for pituitary surgery: Recent trends and advancements.

Authors:  Sukhminderjit Singh Bajwa; Sukhwinder Kaur Bajwa
Journal:  Indian J Endocrinol Metab       Date:  2011-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.